BRPI0810197A2 - Formas sólidas de (e)-1-(4-((1r,2s,3r)-1,2,3,4-tetra-hidroxibutil)-1h-imidazo l-2-il)etanona oxima - Google Patents

Formas sólidas de (e)-1-(4-((1r,2s,3r)-1,2,3,4-tetra-hidroxibutil)-1h-imidazo l-2-il)etanona oxima

Info

Publication number: BRPI0810197A2
Authority: BR; Brazil
Prior art keywords: tetrahydroxibutil; oxima; ethanone; imidazo; solid forms
Prior art date: 2007-04-12

Application number

BRPI0810197-3A2A

Other languages

English (en)

Inventor

Wenxue Wu

Haiming Zhang

Original Assignee

Lexicon Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-12

Filing date

2008-04-11

Publication date

2014-12-30

2008-04-11 Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc

2014-12-30 Publication of BRPI0810197A2 publication Critical patent/BRPI0810197A2/pt

Links

IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 title 1
239000007787 solid Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Immunology (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Hematology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Transplantation (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0810197-3A2A 2007-04-12 2008-04-11 Formas sólidas de (e)-1-(4-((1r,2s,3r)-1,2,3,4-tetra-hidroxibutil)-1h-imidazo l-2-il)etanona oxima BRPI0810197A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US92303707P	2007-04-12	2007-04-12
PCT/US2008/060036 WO2008128045A1 (en)	2007-04-12	2008-04-11	Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime

Publications (1)

Publication Number	Publication Date
BRPI0810197A2 true BRPI0810197A2 (pt)	2014-12-30

Family

ID=39639233

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0810197-3A2A BRPI0810197A2 (pt)	2007-04-12	2008-04-11	Formas sólidas de (e)-1-(4-((1r,2s,3r)-1,2,3,4-tetra-hidroxibutil)-1h-imidazo l-2-il)etanona oxima

Country Status (22)

Country	Link
US (2)	US20080275099A1 (pt)
EP (1)	EP2139865B1 (pt)
JP (1)	JP5496080B2 (pt)
KR (1)	KR20100015464A (pt)
CN (1)	CN101284818B (pt)
AR (1)	AR065979A1 (pt)
AU (1)	AU2008240255B2 (pt)
BR (1)	BRPI0810197A2 (pt)
CA (1)	CA2683963A1 (pt)
CL (1)	CL2008001043A1 (pt)
CO (1)	CO6230981A2 (pt)
EA (1)	EA017042B1 (pt)
EC (1)	ECSP099681A (pt)
ES (1)	ES2453543T3 (pt)
IL (1)	IL201037A (pt)
MX (1)	MX2009010904A (pt)
NZ (1)	NZ579689A (pt)
PE (1)	PE20090072A1 (pt)
TW (1)	TWI412362B (pt)
UY (1)	UY31012A1 (pt)
WO (1)	WO2008128045A1 (pt)
ZA (1)	ZA200906493B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7649098B2 (en) *	2006-02-24	2010-01-19	Lexicon Pharmaceuticals, Inc.	Imidazole-based compounds, compositions comprising them and methods of their use
TW200848029A (en)	2007-03-01	2008-12-16	Lexicon Pharmaceuticals Inc	Heterocyclic compounds, compositions comprising them and methods of their use
AR065980A1 (es)	2007-04-12	2009-07-15	Lexicon Pharmaceuticals Inc	Metodos para preparar compuestos basados en imidazol
TW200920355A (en) *	2007-09-06	2009-05-16	Lexicon Pharmaceuticals Inc	Compositions and methods for treating immunological and inflammatory diseases and disorders
EP2315765B1 (en) *	2008-06-18	2012-12-19	Lexicon Pharmaceuticals, Inc.	Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
US8653126B2 (en)	2010-02-18	2014-02-18	Daiichi Sankyo Company, Limited	Imidazole derivative
JP5757635B2 (ja)	2010-06-28	2015-07-29	第一三共株式会社	培養細胞を用いたｓ１ｐリアーゼ阻害剤のスクリーニング方法
TW201311710A (zh)	2011-06-28	2013-03-16	Daiichi Sankyo Co Ltd	磷酸酯衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4567194A (en) *	1983-03-10	1986-01-28	The Coca-Cola Company	2-Acylimidazole compounds, their synthesis and use as medicinal agents
ZA974811B (en) *	1996-05-31	1997-12-30	Univ Wollongong	Novel therapeutic compounds.
CN101395141A (zh) *	2006-02-24	2009-03-25	莱西肯医药有限公司	咪唑基化合物，包含其的组合物和它们的使用方法
US7649098B2 (en) *	2006-02-24	2010-01-19	Lexicon Pharmaceuticals, Inc.	Imidazole-based compounds, compositions comprising them and methods of their use
AR065980A1 (es) *	2007-04-12	2009-07-15	Lexicon Pharmaceuticals Inc	Metodos para preparar compuestos basados en imidazol

2008
- 2008-03-18 TW TW097109517A patent/TWI412362B/zh not_active IP Right Cessation
- 2008-04-08 AR ARP080101445A patent/AR065979A1/es unknown
- 2008-04-08 UY UY31012A patent/UY31012A1/es not_active Application Discontinuation
- 2008-04-11 CN CN2008100870964A patent/CN101284818B/zh not_active Expired - Fee Related
- 2008-04-11 JP JP2010503233A patent/JP5496080B2/ja active Active
- 2008-04-11 ES ES08745612.5T patent/ES2453543T3/es active Active
- 2008-04-11 EA EA200970940A patent/EA017042B1/ru not_active IP Right Cessation
- 2008-04-11 MX MX2009010904A patent/MX2009010904A/es active IP Right Grant
- 2008-04-11 EP EP08745612.5A patent/EP2139865B1/en not_active Not-in-force
- 2008-04-11 CL CL200801043A patent/CL2008001043A1/es unknown
- 2008-04-11 AU AU2008240255A patent/AU2008240255B2/en not_active Ceased
- 2008-04-11 US US12/101,445 patent/US20080275099A1/en not_active Abandoned
- 2008-04-11 WO PCT/US2008/060036 patent/WO2008128045A1/en not_active Ceased
- 2008-04-11 CA CA002683963A patent/CA2683963A1/en not_active Abandoned
- 2008-04-11 NZ NZ579689A patent/NZ579689A/en not_active IP Right Cessation
- 2008-04-11 PE PE2008000640A patent/PE20090072A1/es not_active Application Discontinuation
- 2008-04-11 KR KR1020097021116A patent/KR20100015464A/ko not_active Ceased
- 2008-04-11 BR BRPI0810197-3A2A patent/BRPI0810197A2/pt not_active IP Right Cessation
2009
- 2009-08-06 US US12/536,714 patent/US8658682B2/en not_active Expired - Fee Related
- 2009-09-17 ZA ZA2009/06493A patent/ZA200906493B/en unknown
- 2009-09-17 IL IL201037A patent/IL201037A/en active IP Right Grant
- 2009-10-07 EC EC2009009681A patent/ECSP099681A/es unknown
- 2009-10-09 CO CO09112459A patent/CO6230981A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ579689A (en)	2011-10-28
JP2010523707A (ja)	2010-07-15
UY31012A1 (es)	2008-09-02
US8658682B2 (en)	2014-02-25
CO6230981A2 (es)	2010-12-20
JP5496080B2 (ja)	2014-05-21
TW200848027A (en)	2008-12-16
AR065979A1 (es)	2009-07-15
CN101284818B (zh)	2012-10-03
AU2008240255A1 (en)	2008-10-23
HK1124851A1 (en)	2009-07-24
MX2009010904A (es)	2009-10-26
EA017042B1 (ru)	2012-09-28
US20090298901A1 (en)	2009-12-03
WO2008128045A8 (en)	2010-01-21
WO2008128045A1 (en)	2008-10-23
ZA200906493B (en)	2010-11-24
PE20090072A1 (es)	2009-02-18
KR20100015464A (ko)	2010-02-12
CA2683963A1 (en)	2008-10-23
IL201037A0 (en)	2010-05-17
EA200970940A1 (ru)	2010-02-26
US20080275099A1 (en)	2008-11-06
ES2453543T3 (es)	2014-04-08
IL201037A (en)	2015-08-31
ECSP099681A (es)	2009-12-28
AU2008240255B2 (en)	2013-07-04
TWI412362B (zh)	2013-10-21
EP2139865B1 (en)	2014-01-01
CL2008001043A1 (es)	2008-09-26
EP2139865A1 (en)	2010-01-06
CN101284818A (zh)	2008-10-15

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2016-03-29	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0923786A2 (pt)	2016-07-26	compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
BRPI0920598A2 (pt)	2015-12-29	formas sólidas de n-(4(7-azabiciclo[2.2.1]heptan-7-il)-2-(triflúor-metil)fenil)-4-oxo-5-(triflúor-metil)-1,4-di-hidroquinolina-3-carboxamida
SMP200900085B (it)	2010-11-12	3-imidazolil-indoli per il trattamento di malattieproliferative.
CY2013047I2 (el)	2015-11-04	Ενωσεις διαρυλυδαντοϊνης
DK3056214T3 (da)	2019-05-13	Hidtil ukendte adjuvanssammensætninger
BRPI0914772A2 (pt)	2015-10-20	compostos heterocíclicos 1,2-dissubstituídos
DK1979356T3 (da)	2013-11-18	Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer
EP2079466A4 (en)	2011-09-07	SUBSTITUTED INDOL COMPOUNDS
EP2215755A4 (en)	2012-10-24	IP BASED CALL-DOWN BY AMPLIFIER
BRPI0918433A2 (pt)	2015-09-22	combinação herbicida compreendendo difluormetano sulfonilanildas substittuídas por demetoxitriazinila.
NL1031385A1 (nl)	2006-09-20	Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen.
BRPI0923048A2 (pt)	2018-09-25	"composto de aminopirazol".
DE502006000770D1 (de)	2008-06-26	Konservierungsmittel
EP1881773A4 (en)	2009-10-28	LOCKING CHUCK
ATE479676T1 (de)	2010-09-15	Als antikoagulanzien verwendbare phenylglycinamid-derivate
DK3348624T3 (da)	2021-03-29	Sammensætninger, der omfatter hfc-1234yf
EP2358768A4 (en)	2012-06-20	Crosslinked polyvinylpyrrolidone compositions
IL201037A0 (en)	2010-05-17	Solid forms of (e)-1-(4-(1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone oxime
DE112005003586A5 (de)	2008-03-06	Bohrfutter
NL1031335A1 (nl)	2006-09-12	Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.
DE502006001027D1 (de)	2008-08-14	Cyanuraten
BRPI0914167A2 (pt)	2015-10-20	formas sólidas de (1r,2s,3r)-1-(2-(isoxa-zol-3-il)-1h-imidazol-4il) butano-1,2,3,4-tetraol e métodos de uso das mesmas
EP1853274A4 (en)	2010-12-15	2-METHYLENE-19-NOR- (20S-24S) - 1ALPHA, 25-D HYDROXYVITAMINE-D2
DK2097400T3 (da)	2013-10-14	Kondenseret, substitueret aminopyrrolidinderivat
EP1880856A4 (en)	2011-03-02	INKJET RECORDING APPARATUS